Hepatitis B vaccines given at birth have essentially eliminated the disease in kids. A vote this week could upend that ...

As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

HIV burden in the South-East Asia Region remains substantial with 88,000 people newly infected, and around 50,000 people ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global ...

The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute ...

HCV—can persist in the livers of those infected and even lead to liver disease or failure in extreme cases. It affects tens ...

Although treatment with direct acting antivirals reduced hepatic steatosis in patients with chronic hepatitis C and fatty ...

Chronic hepatitis C infection has been linked to a higher risk of pancreatic cancer. Learn more about findings from a major ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...

A new study from Yale School of Medicine researchers has found a positive link between chronic hepatitis C and pancreatic ...

This retrospective cohort study used data from the Veterans Health Administration to assess the association between chronic untreated HCV and incident PDAC and whether different HCV genotypes affect ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...